1. Clinical validation of EDIT-B test for the diagnosis of bipolar disorder. (1st June 2022) Authors: Abraham, J.-D.; Salvetat, N.; Guerra, P.; Ferrari, M.; Le Guen, P.; Biglia, O.; Henry, C.; Kessing, L.; Haro, J.M.; Vieta, E.; Weissmann, D. Journal: European psychiatry Issue: Volume 65:Supplement 1(2022) Page Start: S413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Game changer in the diagnosis of bipolar disorder using RNA editing-based blood biomarkers. (13th April 2021) Authors: Abraham, J.-D.; Salvetat, N.; Checa-Robles, F.; Patel, V.; Cayzac, C.; Dubuc, B.; Vetter, D.; Lang, J.-P.; Courtet, P.; Kupfer, D.; Weissmann, D. Journal: European psychiatry Issue: Volume 64:Supplement 1(2021) Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IND02-05 The NeuroDeRisk toolbox: DeRisking chemical structures for neurotoxic adverse outcomes. (1st September 2022) Authors: Bryant, S.D.; Ibis, G.; Seidel, T.; Kohlbacher, S.; Heider, J.; Ernst, M.; Bampali, K.; Koniuszewski, F.; Virvilis, V.; Lekka, E.; Persidis, A.; Mayache, M.-A.; Weissmann, D.; Langer, T. Journal: Toxicology letters Issue: Volume 368(2022)supplement 1 Page Start: S82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗